Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,341 | -34,811 | -22,043 | -25,295 | -200,403 |
| Depreciation Amortization | 2,321 | 1,708 | 1,155 | 577 | 2,379 |
| Accounts receivable | 1,089 | 1,139 | 1,290 | 1,026 | -2,463 |
| Accounts payable and accrued liabilities | -30,222 | -24,573 | -10,569 | -21,692 | 14,801 |
| Other Working Capital | -26,894 | -22,346 | -8,034 | -19,237 | 14,238 |
| Other Operating Activity | 36,196 | 28,265 | 11,416 | 20,843 | -7,332 |
| Operating Cash Flow | $-67,851 | $-50,618 | $-26,785 | $-43,778 | $-178,780 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 113,020 | 108,190 | 56,065 | 40,582 | -14,347 |
| PPE Investments | N/A | N/A | N/A | N/A | -1,031 |
| Investing Cash Flow | $113,020 | $108,190 | $56,065 | $40,582 | $-15,378 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -48,000 | -45,000 | -45,000 | N/A | N/A |
| Common Stock Issued | 73 | -572 | N/A | N/A | 64 |
| Common Stock Repurchased | -572 | N/A | -572 | -572 | -1,730 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 240,015 |
| Financing Cash Flow | $-48,499 | $-45,572 | $-45,572 | $-572 | $238,349 |
| Beginning Cash Position | 66,656 | 66,656 | 66,656 | 66,656 | 22,465 |
| End Cash Position | 63,326 | 78,656 | 50,364 | 62,888 | 66,656 |
| Net Cash Flow | $-3,330 | $12,000 | $-16,292 | $-3,768 | $44,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,851 | -50,618 | -26,785 | -43,778 | -178,780 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1,031 |
| Free Cash Flow | -67,851 | -50,618 | -26,785 | -43,778 | -179,811 |